Showing results (171-180 of 231) with videos related to
Sort By:
Pageof 24
Child Maltreatment|November 21, 2024
Early Exposure to Deprivation or Threat Moderates Expected Associations Between Neural Structure and Age in Adolescent GirlsKathryn Garrisi, Angelina Pei-Tzu Tsai, Kinjal K Patel, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 24, 2018
Effect of Donor Age and Donor Relatedness on Time to Allogeneic Hematopoietic Cell Transplantation in Acute LeukemiaAlissa Visram, Joseph Aziz, Adam Bryant, et al.Internal Medicine Journal|August 8, 2017
Bisphosphonate guidelines for treatment and prevention of myeloma bone diseaseOi Lin Lee, Noemi Horvath, Cindy Lee, et al.The New England Journal of Medicine|June 3, 2024
Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple MyelomaMeletios Athanasios Dimopoulos, Meral Beksac, Ludek Pour, et al.Haematologica|June 30, 2022
The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cellsKelden Richardson, Simon P Keam, Joe Jiang Zhu, et al.Cytotherapy|September 3, 2022
Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host diseaseRutvij A Khanolkar, Gaurav Tripathi, Poonam Dharmani-Khan, et al.Cytokine|January 12, 2010
IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markersSarah C Sasson, Sandy Smith, Nabila Seddiki, et al.Nature|October 28, 2016
T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironmentsEdwin D Hawkins, Delfim Duarte, Olufolake Akinduro, et al.Developmental Cognitive Neuroscience|February 15, 2024
Brain network connectivity during peer evaluation in adolescent females: Associations with age, pubertal hormones, timing, and statusAndrea Pelletier-Baldelli, Margaret A Sheridan, Marc D Rudolph, et al.European Journal of Haematology|July 3, 2024
A single-day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapiesEric Wenlong Li, Esther Jones, Christian Bryant, et al.Pageof 24